13.03.2017 Views

Turkish Journal of Hematology Volume: 34 - Issue: 1

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

TURKISH JOURNAL OF HEMATOLOGY<br />

INSTRUCTIONS FOR AUTHORS<br />

The <strong>Turkish</strong> <strong>Journal</strong> <strong>of</strong> <strong>Hematology</strong> accepts invited review articles, research<br />

articles, brief reports, letters to the editor, and hematological images that<br />

are relevant to the scope <strong>of</strong> hematology, on the condition that they have<br />

not been previously published elsewhere. Basic science manuscripts,<br />

such as randomized, cohort, cross-sectional, and case-control studies,<br />

are given preference. All manuscripts are subject to editorial revision<br />

to ensure they conform to the style adopted by the journal. There is a<br />

double-blind reviewing system. Review articles are solicited by the Editorin-Chief.<br />

Authors wishing to submit an unsolicited review article should<br />

contact the Editor-in-Chief prior to submission in order to screen the<br />

proposed topic for relevance and priority.<br />

The <strong>Turkish</strong> <strong>Journal</strong> <strong>of</strong> <strong>Hematology</strong> does not charge any article submission<br />

or processing charges.<br />

Manuscripts should be prepared according to ICMJE guidelines (http://<br />

www.icmje.org/). Original manuscripts require a structured abstract. Label<br />

each section <strong>of</strong> the structured abstract with the appropriate subheading<br />

(Objective, Materials and Methods, Results, and Conclusion). Letters to<br />

the editor do not require an abstract. Research or project support should<br />

be acknowledged as a footnote on the title page. Technical and other<br />

assistance should be provided on the title page.<br />

Original Manuscripts<br />

Title Page<br />

Title: The title should provide important information regarding the<br />

manuscript’s content. The title must specify that the study is a cohort<br />

study, cross-sectional study, case-control study, or randomized study (i.e.<br />

Cao GY, Li KX, Jin PF, Yue XY, Yang C, Hu X. Comparative bioavailability<br />

<strong>of</strong> ferrous succinate tablet formulations without correction for baseline<br />

circadian changes in iron concentration in healthy Chinese male<br />

subjects: A single-dose, randomized, 2-period crossover study. Clin Ther<br />

2011;33:2054-2059).<br />

The title page should include the authors’ names, degrees, and institutional/<br />

pr<strong>of</strong>essional affiliations and a short title, abbreviations, keywords, financial<br />

disclosure statement, and conflict <strong>of</strong> interest statement. If a manuscript<br />

includes authors from more than one institution, each author’s name<br />

should be followed by a superscript number that corresponds to their<br />

institution, which is listed separately. Please provide contact information<br />

for the corresponding author, including name, e-mail address, and<br />

telephone and fax numbers.<br />

Running Head: The running head should not be more than 40 characters,<br />

including spaces, and should be located at the bottom <strong>of</strong> the title page.<br />

Word Count: A word count for the manuscript, excluding abstract,<br />

acknowledgments, figure and table legends, and references, should be<br />

provided and should not exceed 2500 words. The word count for the<br />

abstract should not exceed 300 words.<br />

Conflict <strong>of</strong> Interest Statement: To prevent potential conflicts <strong>of</strong><br />

interest from being overlooked, this statement must be included in each<br />

manuscript. In case there are conflicts <strong>of</strong> interest, every author should<br />

complete the ICMJE general declaration form, which can be obtained at<br />

www.icmje.org/downloads/coi_disclosure.pdf.<br />

Abstract and Keywords: The second page should include an abstract<br />

that does not exceed 300 words. For manuscripts sent by authors in<br />

Turkey, a title and abstract in <strong>Turkish</strong> are also required. As most readers<br />

read the abstract first, it is critically important. Moreover, as various<br />

electronic databases integrate only abstracts into their index, important<br />

findings should be presented in the abstract.<br />

Objective: The abstract should state the objective (the purpose <strong>of</strong> the<br />

study and hypothesis) and summarize the rationale for the study.<br />

Materials and Methods: Important methods should be written<br />

respectively.<br />

Results: Important findings and results should be provided here.<br />

Conclusion: The study’s new and important findings should be<br />

highlighted and interpreted.<br />

Other types <strong>of</strong> manuscripts, such as reviews, brief reports, and<br />

editorials, will be published according to uniform requirements.<br />

Provide 3-10 keywords below the abstract to assist indexers. Use<br />

terms from the Index Medicus Medical Subject Headings List<br />

(for randomized studies a CONSORT abstract should be provided: http://<br />

www.consort-statement.org).<br />

Introduction: The introduction should include an overview <strong>of</strong> the<br />

relevant literature presented in summary form (one page), and whatever<br />

remains interesting, unique, problematic, relevant, or unknown about<br />

the topic must be specified. The introduction should conclude with the<br />

rationale for the study, its design, and its objective(s).<br />

Materials and Methods: Clearly describe the selection <strong>of</strong> observational<br />

or experimental participants, such as patients, laboratory animals, and<br />

controls, including inclusion and exclusion criteria and a description <strong>of</strong> the<br />

source population. Identify the methods and procedures in sufficient detail<br />

to allow other researchers to reproduce your results. Provide references<br />

to established methods (including statistical methods), provide references<br />

to brief modified methods, and provide the rationale for using them and<br />

an evaluation <strong>of</strong> their limitations. Identify all drugs and chemicals used,<br />

including generic names, doses, and routes <strong>of</strong> administration. The section<br />

should include only information that was available at the time the plan<br />

or protocol for the study was devised (http://www.strobe-statement.org/<br />

fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_combined.<br />

pdf).<br />

Statistics: Describe the statistical methods used in enough detail to<br />

enable a knowledgeable reader with access to the original data to verify<br />

A-IV

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!